Pretransplantation tumor necrosis factor-α production predicts acute rejection after liver transplantation

Liver Transplantation

Volumn 6, Issue 6, 2000, Pages 721-727

  Bathgate, Andrew J ^a   Lee, Patricia ^a   Hayes, Peter C ^a   Simpson, Kenneth J ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DEXAMETHASONE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; MONONUCLEAR CELL; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

EID: 0033741487     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2000.18472     Document Type: Article

References (37)

1. Transcription factors of the NFAT family: Regulation and function
2. Effects of the immunosuppressive drugs CsA and FKS06 on intracellular signalling and gene regulation
3. FK506 and cyclosporin A enhance IL-6 production in monocytes: A single-cell assay
4. Differential effects of the immunosuppressants cyclosporin A, FK506, and KM2210 on cytokine gene expression
5. Differences in the mode of action of cyclosporin and FK 506
6. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome
7. The role of tumour necrosis factor in allograft rejection. I. Evidence that elevated levels of tumour necrosis factor-alpha predict rejection following orthotopic liver transplantation
8. Correlation of peripheral blood lymphocyte and intragraft cytokine mRNA expression with rejection in orthotopic liver transplantation
9. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation
10. Intragraft cytokine profile during human liver allograft rejection
11. Low level of interleukin-10 synthesis during allograft rejection
12. Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcription and semiquantitative polymerase chain reaction amplification
13. Cytokines and the liver
14. Impaired lipopolysaccharide-inducible tumor necrosis factor production in vitro by peripheral blood monocytes of patients with viral hepatitis
15. Banff schema for grading liver allograft rejection and international consensus document
16. Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection
17. Expression of tumour necrosis factor-alpha gene during allograft rejection following rat liver transplantation
18. The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection
19. Intragraft expression of IL-10 messenger RNA: A novel correlate of renal allograft rejection
20. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients
21. In vitro cytokine profiles and their relevance to acute rejection following renal transplantation
22. The importance of the effect of underlying disease on rejection outcomes following orrhotopic liver transplantation
23. Incidence of rejection and infection after liver transplantation as a function of the primary disease: Possible influence of alcohol and polyclonal immunoglobulins
24. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single cell level
25. Distinctive calcineurindependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells
26. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis
27. IL-6, IL-8 and TNF production by cytokine and lipolysaccharide-stimulated human renal cortical epithelial cells in vitro
28. Molecular identification of porcine interleukin-10: Regulation of expression in a kidney allograft model
29. Comparison of the mechanisms regulating IL-5, IL-4, and three other lymphokine genes in the Th2 clone D10.G4.1
30. Molecular and cellular events implicated in local tolerance to kidney allografts in miniature swine
31. A dual mechanism of immunosuppression by FK-506
32. Combined effects of FK506 (tacrolimus) and cyclophosphamide on arypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice
33. Substance P augments interleukin-10 and tumor necrosis factor-alpha release by human cord blood monocytes and macrophages
34. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells
35. Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients
36. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
37. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures